title: Radical resection for pancreatic cancer.
abstract: Ductal adenocarcinoma of the pancreas is still characterized by (1) poor prognosis after surgery and (2) extreme difficulty in early diagnosis, and we need a breakthrough. For the first problem, we have performed a wide range of lymphatic and connective tissue clearance (extended pancreatectomy) which has succeeded in improving the 5-year survival rate from 8% to 24% via decreasing the incidence of locoregional recurrence. When liver perfusion chemotherapy via the hepatic artery and the portal vein was added to the patients who had received extended pancreatectomy, the 5-year survival rate was further elevated to 40% via decreasing the incidence of hepatic metastasis. We conclude that pancreatic cancer should be treated by the better-balanced treatments between locoregional control and prevention of hepatic metastasis. For the second problem, we have more actively collected pancreatic juice to perform cytodiagnosis even though no obvious tumor was delineated by the conventional imaging diagnoses. When cancer cells were detected in the pancreatic juice, our method of intraoperative cytology was very useful in precisely locating the occult lesion indicating an appropriate range of pancreatectomy. The resected pancreas was proven to have included borderline malignancy and in situ or minimally-invasive carcinoma by the postoperative histology, and disease-free 5-year survival rate was 100%. In the future, we need to detect patients with a high risk of pancreatic cancer and develop a less-painful method to collect the pancreatic juice.
authors.affiliation: Department of Surgery, Internal Medicine, Osaka Medical Center for Cancer and Cardiovascular Diseases, 3-Nakamichi, 1-chome, Higashinari-ku, Osaka, 537, Japan.
authors.forename: Osamu
authors.initials: O
authors.lastname: Ishikawa
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Ohigashi
authors.forename: Terumasa
authors.initials: T
authors.lastname: Yamada
authors.forename: Yo
authors.initials: Y
authors.lastname: Sasaki
authors.forename: Shingi
authors.initials: S
authors.lastname: Imaoka
authors.forename: Akihiko
authors.initials: A
authors.lastname: Nakaizumi
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Uehara
authors.forename: Sachiko
authors.initials: S
authors.lastname: Tanaka
authors.forename: Akemi
authors.initials: A
authors.lastname: Takenaka
mesh_terms: D000230:Adenocarcinoma / Q000401:mortality / Q000601:surgery*; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary; D009364:Neoplasm Recurrence, Local; D010180:Pancreatectomy; D010189:Pancreatic Juice / Q000166:cytology; D010190:Pancreatic Neoplasms / Q000401:mortality / Q000601:surgery*